Roelof Rongen
CIK: 0001698966
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GRI Bio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 18, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
23.6K shares- - Aug 26, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
6K shares- - Aug 13, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
4.5K shares- - Jan 23, 2025GRI
GRI Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
30.3K shares at avg. $0.69-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 18, 2025 | GRI GRI Bio, Inc. | Award(A) Stock Option (Right to Buy) | 23,605 | - | - | Direct |
| Aug 26, 2025 | GRI GRI Bio, Inc. | Award(A) Stock Option (Right to Buy) | 5,994 | - | - | Direct |
| Aug 13, 2025 | GRI GRI Bio, Inc. | Award(A) Stock Option (Right to Buy) | 4,527 | - | - | Direct |
| Jan 23, 2025 | GRI GRI Bio, Inc. | Award(A) Stock Option (Right to Buy) | 30,297 | $0.69 | - | Direct |
1-4 of 4 transactions
About Rongen Roelof
Rongen Roelof (SEC CIK 0001698966) files insider reports with the SEC as Director of GRI Bio, Inc. (GRI).
Signal8 holds 4 ownership filings by Rongen Roelof, all Form 4s, filed between Jan 24, 2025 and Sep 22, 2025. Those filings report 4 transactions, from Jan 23, 2025 to Sep 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Rongen Roelof's filings is in LA JOLLA, CA.
Recent filings by Rongen Roelof
- Sep 18, 2025: Grant or award of GRI derivative securities (Form 4, code A).
- Aug 26, 2025: Grant or award of GRI derivative securities (Form 4, code A).
- Aug 13, 2025: Grant or award of GRI derivative securities (Form 4, code A).
- Jan 23, 2025: Grant or award of GRI derivative securities (Form 4, code A).
Other insiders filing for GRI Bio, Inc. (GRI)
- Kelly Leanne, Chief Financial Officer
- Szekeres David Leslie, Director
- Baker David Charles, Director
- SIMPSON CAMILLA V, Director
- Chaturvedi Vipin, Chief Scientific Officer
- Hertz Walter Marc, Chief Executive Officer